Cart
sales@molnova.com
Dihydrouracil
CAS No. 504-07-4
Dihydrouracil( 56-Dihydrouracil )
Catalog No. M19694 CAS No. 504-07-4
56-Dihydrouracil is an intermediate breakdown product of uracil.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydrouracil
-
NoteResearch use only, not for human use.
-
Brief Description56-Dihydrouracil is an intermediate breakdown product of uracil.
-
Description56-Dihydrouracil is an intermediate breakdown product of uracil.
-
In Vitro——
-
In Vivo——
-
Synonyms56-Dihydrouracil
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number504-07-4
-
Formula Weight114.1
-
Molecular FormulaC4H6N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C1CCNC(=O)N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sreekumar A et al.Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.
molnova catalog
related products
-
L-Norleucine
L-Norleucine is an isomer of leucine specifically affects protein synthesis in skeletal muscle and has antivirus activity.
-
3-Indoleacrylic acid
3-Indoleacrylic acid is a metabolite of tryptophan produced by Peptostreptococcus species. 3-Indoleacrylic acid has a beneficial effect on intestinal epithelial barrier function and mitigates inflammatory responses by immune cells.
-
1-Methylhistamine di...
1-Methylhistamine dihydrochloride is a major metabolite of histamine by histamine N-methyltransferase in the pathway of histidine metabolism.?It has been used as a biomarker of histaminergic system activity in the brains of Alzheimer's disease patients as well as those with hypersomnia and other neurological conditions.
